| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/21/1999 | WO1999002187A2 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002183A2 A method of inducing a ctl response |
| 01/21/1999 | WO1999002181A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 01/21/1999 | WO1999002180A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | WO1999002179A1 Axin gene and uses thereof |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002177A1 Pharmaceutical composition containing peptichemio |
| 01/21/1999 | WO1999002176A1 Methods for treating parasitic infection using thiopeptides |
| 01/21/1999 | WO1999002175A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | WO1999002174A1 Non-human pdgf-b-deficient transgenic animals with reduced or non-existent numbers of pericytes |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | WO1999002170A1 Absorption of minerals by intestinal cells |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | WO1999002153A1 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases |
| 01/21/1999 | WO1999002146A1 Amino acid derivatives |
| 01/21/1999 | WO1998049312A3 Nucleic acids, proteins, and methods of use of granulocytic erhlichia |
| 01/21/1999 | WO1998048025A3 Regulatory system for inducible expression of genes with lambdoid promoters |
| 01/21/1999 | WO1998047913A3 Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog |
| 01/21/1999 | WO1998047497A3 Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections |
| 01/21/1999 | WO1998046640A3 Methods and compositions for inducing immunosuppression |
| 01/21/1999 | WO1998043657A3 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 01/21/1999 | WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | DE19730786A1 New human neutrophil-lymphocyte peptide and its fragments |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2297187A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | CA2296581A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 01/21/1999 | CA2296093A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | CA2296071A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | CA2296068A1 Novel bacteriocins, transport and vector system and method of use thereof |
| 01/21/1999 | CA2295964A1 A method of inducing a ctl response |
| 01/21/1999 | CA2295924A1 Methods for treating parasitic infection using thiopeptides |
| 01/21/1999 | CA2295914A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | CA2295908A1 New human growth regulator protein |
| 01/21/1999 | CA2295860A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | CA2295735A1 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2295320A1 Coffee storage proteins |
| 01/21/1999 | CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | CA2295202A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2294865A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/21/1999 | CA2294752A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2292451A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/21/1999 | CA2290736A1 Interleukin-3 gene therapy for cancer |
| 01/21/1999 | CA2290038A1 Chaperone fragments |
| 01/21/1999 | CA2289981A1 Polyol compounds, their production and use |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892053A2 production of recombinant HPMBQ91 polypeptide and uses thereof |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0892048A2 XAF genes and polypeptides and their use for modulating apoptosis |
| 01/20/1999 | EP0892047A2 Human and murine semaphorin L |
| 01/20/1999 | EP0892045A2 Process for the production of a preparation containing hyaluronidase |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891779A1 Pharmaceutical combinations containing parathyroid hormone and calcium and/or phosphor compounds |
| 01/20/1999 | EP0891778A2 Agents for the prevention and/or treatment of radiation-induced disorders |
| 01/20/1999 | EP0891551A1 Protein phosphatase-1 catalytic subunit interactions |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891427A1 Expression of hgv antigens and their use |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891423A1 Genetic suppression and replacement |
| 01/20/1999 | EP0891422A1 Complex superoxide dismutase product |
| 01/20/1999 | EP0891420A1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 01/20/1999 | EP0891378A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891376A1 Antifungal peptides from scleroderma texense |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891347A1 Triterpene derivatives with immunosuppressant activity |
| 01/20/1999 | EP0891331A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0891184A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 01/20/1999 | EP0792288B1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0668877B1 Displacement chromatography process and purified hemoglobin product |
| 01/20/1999 | EP0656908B1 Use of specific binding molecules in potentiating igf-i activity |